Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Journal of Surgical Orthopaedic Advances|January 5, 2012
The use of osteo-conductive stem-cells allograft in lumbar interbody fusion procedures: an alternative to recombinant human bone morphogenetic proteinEubulus J Kerr, Ajay Jawahar, Terry Wooten, et al.Primary Care Respiratory Journal : Journal of the General Practice Airways Group|February 26, 2009
The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional surveyMike Thomas, Stephen Kay, James Pike, et al.Methods of Information in Medicine|July 4, 2020
From Raw Data to FAIR Data: The FAIRification Workflow for Health ResearchA Anil Sinaci, Francisco J Núñez-Benjumea, Mert Gencturk, et al.American Journal of Pharmaceutical Education|June 11, 2009
Post-PharmD industry fellowship opportunities and proposed guidelines for uniformityPaul A Larochelle, Dan K Giang, Matthew A Silva, et al.Journal of Pharmaceutical Sciences|January 30, 2022
Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple MethodsVaida Linkuvienė, Emma L Ross, Lindsey Crawford, et al.Studies in Health Technology and Informatics|August 23, 2024
Childhood Cancer Survivorship Passport Challenges in the European Health Data SpaceRoberta Gazzarata, Michael Strübin, Catherine Chronaki, et al.Current Medical Research and Opinion|July 11, 2022
Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1LKaren L Reckamp, Huamao M Lin, Holly Cranmer, et al.Studies in Health Technology and Informatics|May 20, 2022
Factors Influencing Implementation of the Survivorship Passport: The IT PerspectiveCatherine Chronaki, Eliana Charalambous, Giorgio Cangioli, et al.Future Oncology (London, England)|May 24, 2022
Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancerKaren L Reckamp, Huamao M Lin, Holly Cranmer, et al.Studies in Health Technology and Informatics|August 23, 2024
Assessment of HL7 FHIR Interoperability Between EHR Systems and the Survivorship Passport v2.0 Platform to Generate Treatment Summaries for Childhood Cancer Survivors in Six Clinics: Preliminary Testing ResultsDavide Saraceno, Catherine Chronaki, Giorgio Cangioli, et al.Pageof 5